Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

NCT06938945 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BEHAVIORAL: Digitized patient-reported outcomes

Sponsor

Wei Xiaoping